Attached files
| file | filename |
|---|---|
| EX-32 - EX-32 - Theravance Biopharma, Inc. | ex-32.htm |
| EX-31.2 - EX-31.2 - Theravance Biopharma, Inc. | ex-31d2.htm |
| EX-31.1 - EX-31.1 - Theravance Biopharma, Inc. | ex-31d1.htm |
| EX-23.1 - EX-23.1 - Theravance Biopharma, Inc. | ex-23d1.htm |
| EX-10.68 - EX-10.68 - Theravance Biopharma, Inc. | ex-10d68.htm |
| EX-10.67 - EX-10.67 - Theravance Biopharma, Inc. | ex-10d67.htm |
| EX-4.10 - EX-4.10 - Theravance Biopharma, Inc. | ex-4d10.htm |
| 10-K - 10-K - Theravance Biopharma, Inc. | tbph-20191231x10kc43919.htm |
Exhibit 21.1
Subsidiaries
Theravance Biopharma US, Inc. (Delaware)
Theravance Biopharma R&D, Inc. (Cayman Islands)
Theravance Biopharma UK Limited (England and Wales)
Theravance Biopharma Ireland Limited (Ireland)
Theravance Biopharma R&D IP, LLC (Delaware)
Theravance Biopharma Antibiotics IP, LLC (Delaware)
Triple Royalty Sub LLC (Delaware)